Jim Tananbaum Headshot
Report a problem with this profile
[email protected]

Jim Tananbaum  

CEO and Managing Director, Foresite Capital

Foresite Capital CEO Jim Tananbaum, a newcomer to this year's Midas List, has had notable hits in the last five years in Puma Biotechnology and Intarcia Therapeutics. Before Foresite, Tananbaum was a founding partner of Prospect Venture Partners II and III and was founder and CEO of Theravance (current market cap of $3.5 billion). Early in his career, Tananbaum was a partner at Sierra Ventures and helped establish its healthcare service investment practice. Other investments led by Tananbaum include Amira Pharmaceuticals (acquired Bristol Myers-Squibb), Amerigroup (IPO), Healtheon, and Jazz Pharmaceuticals (IPO).

Related Speakers View all

More like Jim